Company intelligence / Profile preview

Watchbird

Norway

Ownership: Private
Development stage: Commercial

Overview

Watchbird is developing wearable sensor platforms to detect, monitor, diagnose, and communicate health hazards—specifically chemical, biological, radiological, and nuclear threats—to protect soldiers during training and operations. Their main products include the "CBRN mini multi-sensor" for real-time threat detection/warning and the "SAFE sensor" for individual health status/risk monitoring. They are also developing a low-level respiratory protection device ("SAFEgaiter") in collaboration with Norwegian defense partners. No clinical trial results reported; focus is on operational field testing/prototyping.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: DeviceSensor-based monitoring system
Industry: Physiological Monitoring

Partnerships

Norwegian Defence Research Establishment (FFI)

Beyond the preview

Go deeper on Watchbird.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Watchbird.

Explore the full profile